North American Actuarial Journal
Volume 27, 2023 - Issue 4
Open access
900
Views
0
CrossRef citations to date
0
Altmetric
Feature Articles
Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW
Sabyasachi Ghosh1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information
, Ian Smith2 OptumInsight, Eden Prairie, MinnesotaView further author information
, James Davidson2 OptumInsight, Eden Prairie, MinnesotaView further author information
, Tao Fan1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsCorrespondence[email protected]
View further author information
, View further author information
Ninfa Candela1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information
, Cynthia Tsang1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information
, Troy Koch1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information
& Jason Fehr2 OptumInsight, Eden Prairie, MinnesotaCorrespondence[email protected]
View further author information
show allView further author information
Pages 619-629
|
Published online: 09 Sep 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.